Prentice Wealth Management LLC Sarepta Therapeutics, Inc. Transaction History

Prentice Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$62.69 - $88.44 $6,707 - $9,463	-107 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $1,121 - $1,572	-17 Reduced 13.71%	107 $10,000
Q2 2021 Aug 11, 2021	SELL	$69.38 - $86.75 $416 - $520	-6 Reduced 4.62%	124 $10,000
Q1 2021 Jun 17, 2021	SELL	$72.25 - $168.95 $690,637 - $1.61 Million	-9,559 Reduced 98.66%	130 $10,000
Q1 2021 Jun 08, 2021	BUY	$72.25 - $168.95 $700,030 - $1.64 Million	9,689 New	9,689 $10,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.7B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Prentice Wealth Management LLC with notifications on news.